Pyropheophorbides conjugates and their use in photodynamic therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5314905
SERIAL NO

07973174

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Conjugate are formed by covalently linking a target-specific compound to pyropheophorbide compound which conjugated are injected into a host and accumulate in tumor tissue to a higher degree than surrounding normal tissues. When the pyropheophorbide compound component of the conjugate is exposed to a particular wavelength of light the compound becomes cytotoxic destroying the tumor or diseased tissue without causing irreversible normal tissue damage. The pyropheophorbide compounds have been shown to have a variety of characteristics when used in photodynamic therapy. These characteristics are further improved when the compounds are bound to a target specific component such as a ligand capable of binding to a specific cellular receptor (e.g. growth hormones and growth factors) or an antibody capable of binding to a particular antigen.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HEALTH RESEARCH, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dougherty, Thomas J Grand Island, NY 129 6202
Pandey, Ravindra K Buffalo, NY 61 1007

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation